ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Low Molecular Weight Heparin (LMWHs) Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-20Z7320
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Low Molecular Weight Heparin LMWHs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Low Molecular Weight Heparin (LMWHs) Market Research Report 2024

Code: QYRE-Auto-20Z7320
Report
January 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aspen
Sanofi Aventis
Pfizer Inc
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

Low Molecular Weight Heparin (LMWHs) Market Size

The global Low Molecular Weight Heparin (LMWHs) market was valued at US$ 338.6 million in 2023 and is anticipated to reach US$ 421.2 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.

Low Molecular Weight Heparin (LMWHs) Market

Low Molecular Weight Heparin (LMWHs) Market

Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
 
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da. The Europe and US Low Molecular Weight Heparin revenue was about US$ 1480 million in 2023.
 
Global Low Molecular Weight Heparin main players are Aspen, Sanofi-aventis, CSBIO, Dongying Tiandong Pharmaceutical, Techdow, etc. Top five companies hold a share above 55%. Europe is the largest market, with a share about 38%.
This report aims to provide a comprehensive presentation of the global market for Low Molecular Weight Heparin (LMWHs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Low Molecular Weight Heparin (LMWHs).
 

Report Scope

The Low Molecular Weight Heparin (LMWHs) market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Low Molecular Weight Heparin (LMWHs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Low Molecular Weight Heparin (LMWHs) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
 

Scope of Low Molecular Weight Heparin (LMWHs) Market Report

Report Metric Details
Report Name Low Molecular Weight Heparin (LMWHs) Market
Accounted market size in 2023 US$ 338.6 million
Forecasted market size in 2030 US$ 421.2 million
CAGR 3.1%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Enoxaparin
  • Dalteparin
  • Tinzaparin
  • Fraxiparine
Segment by Application
  • Treatment of Venous Thromboembolism
  • Complications of Pregnancy
  • Cardioversion of Atrial Fibrillation/Flutter
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Low Molecular Weight Heparin (LMWHs) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Low Molecular Weight Heparin (LMWHs) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Low Molecular Weight Heparin (LMWHs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Low Molecular Weight Heparin (LMWHs) Market growing?

Ans: The Low Molecular Weight Heparin (LMWHs) Market witnessing a CAGR of 3.1% during the forecast period 2024-2030.

What is the Low Molecular Weight Heparin (LMWHs) Market size in 2030?

Ans: The Low Molecular Weight Heparin (LMWHs) Market size in 2030 will be US$ 421.2 million.

What is the market share of major companies in Low Molecular Weight Heparin (LMWHs) Market?

Ans: Top five companies hold a share above 55%.

What is the Low Molecular Weight Heparin (LMWHs) Market share by region?

Ans: Europe is the largest market, with a share about 38%.

Who are the main players in the Low Molecular Weight Heparin (LMWHs) Market report?

Ans: The main players in the Low Molecular Weight Heparin (LMWHs) Market are Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group

What are the Application segmentation covered in the Low Molecular Weight Heparin (LMWHs) Market report?

Ans: The Applications covered in the Low Molecular Weight Heparin (LMWHs) Market report are Treatment of Venous Thromboembolism, Complications of Pregnancy, Cardioversion of Atrial Fibrillation/Flutter, Others

What are the Type segmentation covered in the Low Molecular Weight Heparin (LMWHs) Market report?

Ans: The Types covered in the Low Molecular Weight Heparin (LMWHs) Market report are Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine

1 Low Molecular Weight Heparin (LMWHs) Market Overview
1.1 Product Definition
1.2 Low Molecular Weight Heparin (LMWHs) Segment by Type
1.2.1 Global Low Molecular Weight Heparin (LMWHs) Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Low Molecular Weight Heparin (LMWHs) Segment by Application
1.3.1 Global Low Molecular Weight Heparin (LMWHs) Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Low Molecular Weight Heparin (LMWHs) Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Low Molecular Weight Heparin (LMWHs) Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Low Molecular Weight Heparin (LMWHs) Production Estimates and Forecasts (2019-2030)
1.4.4 Global Low Molecular Weight Heparin (LMWHs) Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Low Molecular Weight Heparin (LMWHs) Production Market Share by Manufacturers (2019-2024)
2.2 Global Low Molecular Weight Heparin (LMWHs) Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Low Molecular Weight Heparin (LMWHs), Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Low Molecular Weight Heparin (LMWHs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Low Molecular Weight Heparin (LMWHs) Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Low Molecular Weight Heparin (LMWHs), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Low Molecular Weight Heparin (LMWHs), Product Offered and Application
2.8 Global Key Manufacturers of Low Molecular Weight Heparin (LMWHs), Date of Enter into This Industry
2.9 Low Molecular Weight Heparin (LMWHs) Market Competitive Situation and Trends
2.9.1 Low Molecular Weight Heparin (LMWHs) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Low Molecular Weight Heparin (LMWHs) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Low Molecular Weight Heparin (LMWHs) Production by Region
3.1 Global Low Molecular Weight Heparin (LMWHs) Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Low Molecular Weight Heparin (LMWHs) Production Value by Region (2019-2030)
3.2.1 Global Low Molecular Weight Heparin (LMWHs) Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Low Molecular Weight Heparin (LMWHs) by Region (2025-2030)
3.3 Global Low Molecular Weight Heparin (LMWHs) Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Low Molecular Weight Heparin (LMWHs) Production by Region (2019-2030)
3.4.1 Global Low Molecular Weight Heparin (LMWHs) Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Low Molecular Weight Heparin (LMWHs) by Region (2025-2030)
3.5 Global Low Molecular Weight Heparin (LMWHs) Market Price Analysis by Region (2019-2024)
3.6 Global Low Molecular Weight Heparin (LMWHs) Production and Value, Year-over-Year Growth
3.6.1 North America Low Molecular Weight Heparin (LMWHs) Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Low Molecular Weight Heparin (LMWHs) Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Low Molecular Weight Heparin (LMWHs) Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Low Molecular Weight Heparin (LMWHs) Production Value Estimates and Forecasts (2019-2030)
4 Low Molecular Weight Heparin (LMWHs) Consumption by Region
4.1 Global Low Molecular Weight Heparin (LMWHs) Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Low Molecular Weight Heparin (LMWHs) Consumption by Region (2019-2030)
4.2.1 Global Low Molecular Weight Heparin (LMWHs) Consumption by Region (2019-2024)
4.2.2 Global Low Molecular Weight Heparin (LMWHs) Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Low Molecular Weight Heparin (LMWHs) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Low Molecular Weight Heparin (LMWHs) Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Low Molecular Weight Heparin (LMWHs) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Low Molecular Weight Heparin (LMWHs) Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Low Molecular Weight Heparin (LMWHs) Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Low Molecular Weight Heparin (LMWHs) Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Low Molecular Weight Heparin (LMWHs) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Low Molecular Weight Heparin (LMWHs) Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Low Molecular Weight Heparin (LMWHs) Production by Type (2019-2030)
5.1.1 Global Low Molecular Weight Heparin (LMWHs) Production by Type (2019-2024)
5.1.2 Global Low Molecular Weight Heparin (LMWHs) Production by Type (2025-2030)
5.1.3 Global Low Molecular Weight Heparin (LMWHs) Production Market Share by Type (2019-2030)
5.2 Global Low Molecular Weight Heparin (LMWHs) Production Value by Type (2019-2030)
5.2.1 Global Low Molecular Weight Heparin (LMWHs) Production Value by Type (2019-2024)
5.2.2 Global Low Molecular Weight Heparin (LMWHs) Production Value by Type (2025-2030)
5.2.3 Global Low Molecular Weight Heparin (LMWHs) Production Value Market Share by Type (2019-2030)
5.3 Global Low Molecular Weight Heparin (LMWHs) Price by Type (2019-2030)
6 Segment by Application
6.1 Global Low Molecular Weight Heparin (LMWHs) Production by Application (2019-2030)
6.1.1 Global Low Molecular Weight Heparin (LMWHs) Production by Application (2019-2024)
6.1.2 Global Low Molecular Weight Heparin (LMWHs) Production by Application (2025-2030)
6.1.3 Global Low Molecular Weight Heparin (LMWHs) Production Market Share by Application (2019-2030)
6.2 Global Low Molecular Weight Heparin (LMWHs) Production Value by Application (2019-2030)
6.2.1 Global Low Molecular Weight Heparin (LMWHs) Production Value by Application (2019-2024)
6.2.2 Global Low Molecular Weight Heparin (LMWHs) Production Value by Application (2025-2030)
6.2.3 Global Low Molecular Weight Heparin (LMWHs) Production Value Market Share by Application (2019-2030)
6.3 Global Low Molecular Weight Heparin (LMWHs) Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Aspen
7.1.1 Aspen Low Molecular Weight Heparin (LMWHs) Corporation Information
7.1.2 Aspen Low Molecular Weight Heparin (LMWHs) Product Portfolio
7.1.3 Aspen Low Molecular Weight Heparin (LMWHs) Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Aspen Main Business and Markets Served
7.1.5 Aspen Recent Developments/Updates
7.2 Sanofi-aventis
7.2.1 Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Corporation Information
7.2.2 Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Product Portfolio
7.2.3 Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Sanofi-aventis Main Business and Markets Served
7.2.5 Sanofi-aventis Recent Developments/Updates
7.3 Pfizer
7.3.1 Pfizer Low Molecular Weight Heparin (LMWHs) Corporation Information
7.3.2 Pfizer Low Molecular Weight Heparin (LMWHs) Product Portfolio
7.3.3 Pfizer Low Molecular Weight Heparin (LMWHs) Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Pfizer Main Business and Markets Served
7.3.5 Pfizer Recent Developments/Updates
7.4 Opocrin
7.4.1 Opocrin Low Molecular Weight Heparin (LMWHs) Corporation Information
7.4.2 Opocrin Low Molecular Weight Heparin (LMWHs) Product Portfolio
7.4.3 Opocrin Low Molecular Weight Heparin (LMWHs) Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Opocrin Main Business and Markets Served
7.4.5 Opocrin Recent Developments/Updates
7.5 CSBIO
7.5.1 CSBIO Low Molecular Weight Heparin (LMWHs) Corporation Information
7.5.2 CSBIO Low Molecular Weight Heparin (LMWHs) Product Portfolio
7.5.3 CSBIO Low Molecular Weight Heparin (LMWHs) Production, Value, Price and Gross Margin (2019-2024)
7.5.4 CSBIO Main Business and Markets Served
7.5.5 CSBIO Recent Developments/Updates
7.6 Dongying Tiandong Pharmaceutical
7.6.1 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin (LMWHs) Corporation Information
7.6.2 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin (LMWHs) Product Portfolio
7.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin (LMWHs) Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Dongying Tiandong Pharmaceutical Main Business and Markets Served
7.6.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
7.7 Changzhou Qianhong Bio-pharma
7.7.1 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin (LMWHs) Corporation Information
7.7.2 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin (LMWHs) Product Portfolio
7.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin (LMWHs) Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Changzhou Qianhong Bio-pharma Main Business and Markets Served
7.7.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
7.8 Techdow
7.8.1 Techdow Low Molecular Weight Heparin (LMWHs) Corporation Information
7.8.2 Techdow Low Molecular Weight Heparin (LMWHs) Product Portfolio
7.8.3 Techdow Low Molecular Weight Heparin (LMWHs) Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Techdow Main Business and Markets Served
7.7.5 Techdow Recent Developments/Updates
7.9 Yantai Dongcheng Pharmaceutical Group
7.9.1 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin (LMWHs) Corporation Information
7.9.2 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin (LMWHs) Product Portfolio
7.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin (LMWHs) Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Yantai Dongcheng Pharmaceutical Group Main Business and Markets Served
7.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Low Molecular Weight Heparin (LMWHs) Industry Chain Analysis
8.2 Low Molecular Weight Heparin (LMWHs) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Low Molecular Weight Heparin (LMWHs) Production Mode & Process
8.4 Low Molecular Weight Heparin (LMWHs) Sales and Marketing
8.4.1 Low Molecular Weight Heparin (LMWHs) Sales Channels
8.4.2 Low Molecular Weight Heparin (LMWHs) Distributors
8.5 Low Molecular Weight Heparin (LMWHs) Customers
9 Low Molecular Weight Heparin (LMWHs) Market Dynamics
9.1 Low Molecular Weight Heparin (LMWHs) Industry Trends
9.2 Low Molecular Weight Heparin (LMWHs) Market Drivers
9.3 Low Molecular Weight Heparin (LMWHs) Market Challenges
9.4 Low Molecular Weight Heparin (LMWHs) Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
Aspen
Sanofi Aventis
Pfizer Inc
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
List of Tables
    Table 1. Global Low Molecular Weight Heparin (LMWHs) Market Value by Type, (US$ Million) & (2023 VS 2030)
    Table 2. Global Low Molecular Weight Heparin (LMWHs) Market Value by Application, (US$ Million) & (2023 VS 2030)
    Table 3. Global Low Molecular Weight Heparin (LMWHs) Production Capacity (Kiloton) by Manufacturers in 2023
    Table 4. Global Low Molecular Weight Heparin (LMWHs) Production by Manufacturers (2019-2024) & (Kiloton)
    Table 5. Global Low Molecular Weight Heparin (LMWHs) Production Market Share by Manufacturers (2019-2024)
    Table 6. Global Low Molecular Weight Heparin (LMWHs) Production Value by Manufacturers (2019-2024) & (US$ Million)
    Table 7. Global Low Molecular Weight Heparin (LMWHs) Production Value Share by Manufacturers (2019-2024)
    Table 8. Global Low Molecular Weight Heparin (LMWHs) Industry Ranking 2022 VS 2023 VS 2024
    Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Low Molecular Weight Heparin (LMWHs) as of 2023)
    Table 10. Global Market Low Molecular Weight Heparin (LMWHs) Average Price by Manufacturers (US$/Ton) & (2019-2024)
    Table 11. Manufacturers Low Molecular Weight Heparin (LMWHs) Production Sites and Area Served
    Table 12. Manufacturers Low Molecular Weight Heparin (LMWHs) Product Types
    Table 13. Global Low Molecular Weight Heparin (LMWHs) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Mergers & Acquisitions, Expansion
    Table 15. Global Low Molecular Weight Heparin (LMWHs) Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 16. Global Low Molecular Weight Heparin (LMWHs) Production Value (US$ Million) by Region (2019-2024)
    Table 17. Global Low Molecular Weight Heparin (LMWHs) Production Value Market Share by Region (2019-2024)
    Table 18. Global Low Molecular Weight Heparin (LMWHs) Production Value (US$ Million) Forecast by Region (2025-2030)
    Table 19. Global Low Molecular Weight Heparin (LMWHs) Production Value Market Share Forecast by Region (2025-2030)
    Table 20. Global Low Molecular Weight Heparin (LMWHs) Production Comparison by Region: 2019 VS 2023 VS 2030 (Kiloton)
    Table 21. Global Low Molecular Weight Heparin (LMWHs) Production (Kiloton) by Region (2019-2024)
    Table 22. Global Low Molecular Weight Heparin (LMWHs) Production Market Share by Region (2019-2024)
    Table 23. Global Low Molecular Weight Heparin (LMWHs) Production (Kiloton) Forecast by Region (2025-2030)
    Table 24. Global Low Molecular Weight Heparin (LMWHs) Production Market Share Forecast by Region (2025-2030)
    Table 25. Global Low Molecular Weight Heparin (LMWHs) Market Average Price (US$/Ton) by Region (2019-2024)
    Table 26. Global Low Molecular Weight Heparin (LMWHs) Market Average Price (US$/Ton) by Region (2025-2030)
    Table 27. Global Low Molecular Weight Heparin (LMWHs) Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kiloton)
    Table 28. Global Low Molecular Weight Heparin (LMWHs) Consumption by Region (2019-2024) & (Kiloton)
    Table 29. Global Low Molecular Weight Heparin (LMWHs) Consumption Market Share by Region (2019-2024)
    Table 30. Global Low Molecular Weight Heparin (LMWHs) Forecasted Consumption by Region (2025-2030) & (Kiloton)
    Table 31. Global Low Molecular Weight Heparin (LMWHs) Forecasted Consumption Market Share by Region (2019-2024)
    Table 32. North America Low Molecular Weight Heparin (LMWHs) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
    Table 33. North America Low Molecular Weight Heparin (LMWHs) Consumption by Country (2019-2024) & (Kiloton)
    Table 34. North America Low Molecular Weight Heparin (LMWHs) Consumption by Country (2025-2030) & (Kiloton)
    Table 35. Europe Low Molecular Weight Heparin (LMWHs) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
    Table 36. Europe Low Molecular Weight Heparin (LMWHs) Consumption by Country (2019-2024) & (Kiloton)
    Table 37. Europe Low Molecular Weight Heparin (LMWHs) Consumption by Country (2025-2030) & (Kiloton)
    Table 38. Asia Pacific Low Molecular Weight Heparin (LMWHs) Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kiloton)
    Table 39. Asia Pacific Low Molecular Weight Heparin (LMWHs) Consumption by Region (2019-2024) & (Kiloton)
    Table 40. Asia Pacific Low Molecular Weight Heparin (LMWHs) Consumption by Region (2025-2030) & (Kiloton)
    Table 41. Latin America, Middle East & Africa Low Molecular Weight Heparin (LMWHs) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
    Table 42. Latin America, Middle East & Africa Low Molecular Weight Heparin (LMWHs) Consumption by Country (2019-2024) & (Kiloton)
    Table 43. Latin America, Middle East & Africa Low Molecular Weight Heparin (LMWHs) Consumption by Country (2025-2030) & (Kiloton)
    Table 44. Global Low Molecular Weight Heparin (LMWHs) Production (Kiloton) by Type (2019-2024)
    Table 45. Global Low Molecular Weight Heparin (LMWHs) Production (Kiloton) by Type (2025-2030)
    Table 46. Global Low Molecular Weight Heparin (LMWHs) Production Market Share by Type (2019-2024)
    Table 47. Global Low Molecular Weight Heparin (LMWHs) Production Market Share by Type (2025-2030)
    Table 48. Global Low Molecular Weight Heparin (LMWHs) Production Value (US$ Million) by Type (2019-2024)
    Table 49. Global Low Molecular Weight Heparin (LMWHs) Production Value (US$ Million) by Type (2025-2030)
    Table 50. Global Low Molecular Weight Heparin (LMWHs) Production Value Share by Type (2019-2024)
    Table 51. Global Low Molecular Weight Heparin (LMWHs) Production Value Share by Type (2025-2030)
    Table 52. Global Low Molecular Weight Heparin (LMWHs) Price (US$/Ton) by Type (2019-2024)
    Table 53. Global Low Molecular Weight Heparin (LMWHs) Price (US$/Ton) by Type (2025-2030)
    Table 54. Global Low Molecular Weight Heparin (LMWHs) Production (Kiloton) by Application (2019-2024)
    Table 55. Global Low Molecular Weight Heparin (LMWHs) Production (Kiloton) by Application (2025-2030)
    Table 56. Global Low Molecular Weight Heparin (LMWHs) Production Market Share by Application (2019-2024)
    Table 57. Global Low Molecular Weight Heparin (LMWHs) Production Market Share by Application (2025-2030)
    Table 58. Global Low Molecular Weight Heparin (LMWHs) Production Value (US$ Million) by Application (2019-2024)
    Table 59. Global Low Molecular Weight Heparin (LMWHs) Production Value (US$ Million) by Application (2025-2030)
    Table 60. Global Low Molecular Weight Heparin (LMWHs) Production Value Share by Application (2019-2024)
    Table 61. Global Low Molecular Weight Heparin (LMWHs) Production Value Share by Application (2025-2030)
    Table 62. Global Low Molecular Weight Heparin (LMWHs) Price (US$/Ton) by Application (2019-2024)
    Table 63. Global Low Molecular Weight Heparin (LMWHs) Price (US$/Ton) by Application (2025-2030)
    Table 64. Aspen Low Molecular Weight Heparin (LMWHs) Corporation Information
    Table 65. Aspen Specification and Application
    Table 66. Aspen Low Molecular Weight Heparin (LMWHs) Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 67. Aspen Main Business and Markets Served
    Table 68. Aspen Recent Developments/Updates
    Table 69. Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Corporation Information
    Table 70. Sanofi-aventis Specification and Application
    Table 71. Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 72. Sanofi-aventis Main Business and Markets Served
    Table 73. Sanofi-aventis Recent Developments/Updates
    Table 74. Pfizer Low Molecular Weight Heparin (LMWHs) Corporation Information
    Table 75. Pfizer Specification and Application
    Table 76. Pfizer Low Molecular Weight Heparin (LMWHs) Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 77. Pfizer Main Business and Markets Served
    Table 78. Pfizer Recent Developments/Updates
    Table 79. Opocrin Low Molecular Weight Heparin (LMWHs) Corporation Information
    Table 80. Opocrin Specification and Application
    Table 81. Opocrin Low Molecular Weight Heparin (LMWHs) Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 82. Opocrin Main Business and Markets Served
    Table 83. Opocrin Recent Developments/Updates
    Table 84. CSBIO Low Molecular Weight Heparin (LMWHs) Corporation Information
    Table 85. CSBIO Specification and Application
    Table 86. CSBIO Low Molecular Weight Heparin (LMWHs) Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 87. CSBIO Main Business and Markets Served
    Table 88. CSBIO Recent Developments/Updates
    Table 89. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin (LMWHs) Corporation Information
    Table 90. Dongying Tiandong Pharmaceutical Specification and Application
    Table 91. Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin (LMWHs) Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 92. Dongying Tiandong Pharmaceutical Main Business and Markets Served
    Table 93. Dongying Tiandong Pharmaceutical Recent Developments/Updates
    Table 94. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin (LMWHs) Corporation Information
    Table 95. Changzhou Qianhong Bio-pharma Specification and Application
    Table 96. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin (LMWHs) Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 97. Changzhou Qianhong Bio-pharma Main Business and Markets Served
    Table 98. Changzhou Qianhong Bio-pharma Recent Developments/Updates
    Table 99. Techdow Low Molecular Weight Heparin (LMWHs) Corporation Information
    Table 100. Techdow Specification and Application
    Table 101. Techdow Low Molecular Weight Heparin (LMWHs) Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 102. Techdow Main Business and Markets Served
    Table 103. Techdow Recent Developments/Updates
    Table 104. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin (LMWHs) Corporation Information
    Table 105. Yantai Dongcheng Pharmaceutical Group Specification and Application
    Table 106. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin (LMWHs) Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 107. Yantai Dongcheng Pharmaceutical Group Main Business and Markets Served
    Table 108. Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates
    Table 109. Key Raw Materials Lists
    Table 110. Raw Materials Key Suppliers Lists
    Table 111. Low Molecular Weight Heparin (LMWHs) Distributors List
    Table 112. Low Molecular Weight Heparin (LMWHs) Customers List
    Table 113. Low Molecular Weight Heparin (LMWHs) Market Trends
    Table 114. Low Molecular Weight Heparin (LMWHs) Market Drivers
    Table 115. Low Molecular Weight Heparin (LMWHs) Market Challenges
    Table 116. Low Molecular Weight Heparin (LMWHs) Market Restraints
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Low Molecular Weight Heparin (LMWHs)
    Figure 2. Global Low Molecular Weight Heparin (LMWHs) Market Value by Type, (US$ Million) & (2023 VS 2030)
    Figure 3. Global Low Molecular Weight Heparin (LMWHs) Market Share by Type: 2023 VS 2030
    Figure 4. Enoxaparin Product Picture
    Figure 5. Dalteparin Product Picture
    Figure 6. Tinzaparin Product Picture
    Figure 7. Fraxiparine Product Picture
    Figure 8. Global Low Molecular Weight Heparin (LMWHs) Market Value by Application, (US$ Million) & (2023 VS 2030)
    Figure 9. Global Low Molecular Weight Heparin (LMWHs) Market Share by Application: 2023 VS 2030
    Figure 10. Treatment of Venous Thromboembolism
    Figure 11. Complications of Pregnancy
    Figure 12. Cardioversion of Atrial Fibrillation/Flutter
    Figure 13. Others
    Figure 14. Global Low Molecular Weight Heparin (LMWHs) Production Value (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Low Molecular Weight Heparin (LMWHs) Production Value (US$ Million) & (2019-2030)
    Figure 16. Global Low Molecular Weight Heparin (LMWHs) Production Capacity (Kiloton) & (2019-2030)
    Figure 17. Global Low Molecular Weight Heparin (LMWHs) Production (Kiloton) & (2019-2030)
    Figure 18. Global Low Molecular Weight Heparin (LMWHs) Average Price (US$/Ton) & (2019-2030)
    Figure 19. Low Molecular Weight Heparin (LMWHs) Report Years Considered
    Figure 20. Low Molecular Weight Heparin (LMWHs) Production Share by Manufacturers in 2023
    Figure 21. Low Molecular Weight Heparin (LMWHs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 22. The Global 5 and 10 Largest Players: Market Share by Low Molecular Weight Heparin (LMWHs) Revenue in 2023
    Figure 23. Global Low Molecular Weight Heparin (LMWHs) Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Figure 24. Global Low Molecular Weight Heparin (LMWHs) Production Value Market Share by Region: 2019 VS 2023 VS 2030
    Figure 25. Global Low Molecular Weight Heparin (LMWHs) Production Comparison by Region: 2019 VS 2023 VS 2030 (Kiloton)
    Figure 26. Global Low Molecular Weight Heparin (LMWHs) Production Market Share by Region: 2019 VS 2023 VS 2030
    Figure 27. North America Low Molecular Weight Heparin (LMWHs) Production Value (US$ Million) Growth Rate (2019-2030)
    Figure 28. Europe Low Molecular Weight Heparin (LMWHs) Production Value (US$ Million) Growth Rate (2019-2030)
    Figure 29. China Low Molecular Weight Heparin (LMWHs) Production Value (US$ Million) Growth Rate (2019-2030)
    Figure 30. Japan Low Molecular Weight Heparin (LMWHs) Production Value (US$ Million) Growth Rate (2019-2030)
    Figure 31. Global Low Molecular Weight Heparin (LMWHs) Consumption by Region: 2019 VS 2023 VS 2030 (Kiloton)
    Figure 32. Global Low Molecular Weight Heparin (LMWHs) Consumption Market Share by Region: 2019 VS 2023 VS 2030
    Figure 33. North America Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 34. North America Low Molecular Weight Heparin (LMWHs) Consumption Market Share by Country (2019-2030)
    Figure 35. Canada Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 36. U.S. Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 37. Europe Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 38. Europe Low Molecular Weight Heparin (LMWHs) Consumption Market Share by Country (2019-2030)
    Figure 39. Germany Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 40. France Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 41. U.K. Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 42. Italy Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 43. Russia Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 44. Asia Pacific Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 45. Asia Pacific Low Molecular Weight Heparin (LMWHs) Consumption Market Share by Regions (2019-2030)
    Figure 46. China Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 47. Japan Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 48. South Korea Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 49. China Taiwan Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 50. Southeast Asia Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 51. India Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 52. Latin America, Middle East & Africa Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 53. Latin America, Middle East & Africa Low Molecular Weight Heparin (LMWHs) Consumption Market Share by Country (2019-2030)
    Figure 54. Mexico Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 55. Brazil Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 56. Turkey Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 57. GCC Countries Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 58. Global Production Market Share of Low Molecular Weight Heparin (LMWHs) by Type (2019-2030)
    Figure 59. Global Production Value Market Share of Low Molecular Weight Heparin (LMWHs) by Type (2019-2030)
    Figure 60. Global Low Molecular Weight Heparin (LMWHs) Price (US$/Ton) by Type (2019-2030)
    Figure 61. Global Production Market Share of Low Molecular Weight Heparin (LMWHs) by Application (2019-2030)
    Figure 62. Global Production Value Market Share of Low Molecular Weight Heparin (LMWHs) by Application (2019-2030)
    Figure 63. Global Low Molecular Weight Heparin (LMWHs) Price (US$/Ton) by Application (2019-2030)
    Figure 64. Low Molecular Weight Heparin (LMWHs) Value Chain
    Figure 65. Low Molecular Weight Heparin (LMWHs) Production Process
    Figure 66. Channels of Distribution (Direct Vs Distribution)
    Figure 67. Distributors Profiles
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions